Advertisement

Topics

MiNA Therapeutics Company Profile

17:47 EST 15th December 2018 | BioPortfolio

MiNA Therapeutics is a biopharmaceutical company pioneering the discovery and development of a new class of medicines that selectively up-regulate proteins inside patient cells. MiNA’s proprietary RNA activation (RNAa) technology platform enables up-regulation of beneficial proteins by the selective and long lasting transcriptional activation of a target gene. RNAa has unique potential to target diseases that are untreatable with today’s conventional medicine. MiNA’s novel drugs, termed small activating RNAs (saRNAs), leverage existing RNA delivery technologies to accelerate the development of drug candidates. The company is developing MTL-CEBPA, a first in class treatment for advanced liver cancer. MiNA was founded in 2008 by pioneering researchers John Rossi, Nagy Habib and Pal Saetrom. The company is privately held and located in London, United Kingdom. To learn more visit www.minatx.com.


News Articles [714 Associated News Articles listed on BioPortfolio]

MiNA Therapeutics Announces Sosei Will Not Exercise Acquisition Option

--MiNA Therapeutics remains on track with current development plans for small activating RNA medicines including clinical development of MTL-CEBPA drug candidate-- MiNA...

Colgate Save Water Message Hits the Trail with Mina Guli As Ultra-Runner Embarks on #RunningDry ...

NEW YORK, Nov. 1, 2018 /PRNewswire/ -- On Sunday, November 4, 2018, water activist and ultra-runner Mina Guli will kick off #RunningDry, an initiative to Read more...

Mina Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryMina Therapeutics Ltd Mina Therapeutics, a subsidiary of MiNA Holdings Ltd is a developer of small activating ribonucleic acid therapeutics that selectively upregulate therapeutic proteins. The...

Mina Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryMina Therapeutics Ltd Mina Therapeutics, a subsidiary of MiNA Holdings Ltd is a developer of small activating ribonucleic acid therapeutics that selectively upregulate therapeutic proteins. The...

RNA Therapy Shows Promise for Treating Liver Cancer

British biotech MiNA Therapeutics’ innovative RNA treatment may enhance liver cancer patients’ response to standard cancer therapies, suggest early results from a Phase I/IIa clinical trial. When ...

Shrink Ray Harmlessly Shoots Laser through Cells

NewsScientists are turning SUVs into small cars with a shrink ray, but at the cellular level.Contributed Author: 

Tung värvning till Cellink

Biobläck-företaget Cellink knyter Mina J Bisell till sitt advisory board.

Lasers Could Aid Memory and Treat Anxiety

NewsSeeing a therapist for anxiety may soon include seeing a laser as well.Contributed Author: 

PubMed Articles [462 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

Evidencia neuroanatómica del transporte del virus de la rabia por la vía propioespinal de la médula espinal de ratones.

Introducción. Es escasa la información sobre los detalles neuroanatómicos del transporte del virus de la rabia en su ascenso por la médula espinal.Objetivos. Identificar la ruta neuroanatómica de...

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [167 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1285 Associated Companies listed on BioPortfolio]

MiNA Therapeutics

MiNA Therapeutics is a biopharmaceutical company pioneering the discovery and development of a new class of medicines that selectively up-regulate proteins inside patient cells. M...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

Click Therapeutics, Inc.

Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavi...

More Information about "MiNA Therapeutics" on BioPortfolio

We have published hundreds of MiNA Therapeutics news stories on BioPortfolio along with dozens of MiNA Therapeutics Clinical Trials and PubMed Articles about MiNA Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MiNA Therapeutics Companies in our database. You can also find out about relevant MiNA Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record